MEI Pharma, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q3 2011 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
MEI Pharma, Inc. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from Q3 2011 to Q3 2023.
  • MEI Pharma, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending September 30, 2023 was $0.000.
  • MEI Pharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$11.9M, a 29570% decline from 2023.
  • MEI Pharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$40K, a 100% decline from 2022.
  • MEI Pharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $49.1M, a 1314% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $0 +$40K Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q3 2022 -$40K +$154K +79.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q3 2021 -$194K -$3.45M -106% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q3 2020 $3.26M -$2.25M -40.8% Jul 1, 2020 Sep 30, 2020 10-Q/A 2022-05-23
Q3 2019 $5.51M +$4.67M +558% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q3 2018 $837K +$817K +4085% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q3 2017 $20K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q3 2011 $2.67M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.